Founded in 1986 BioCryst Pharmaceuticals (BCRX) specializes in the development of novel, oral, small molecules that inhibit enzymes playing a key role in the biological pathway of rare diseases. … [Read more...] about BioCryst Pharmaceuticals (Nasdaq: BCRX): Embarrassment of Riches
La Jolla Pharmaceuticals (Nasdaq: LJPC): An Assessment of The Tetraphase Acquisition
For the past 8-months now our team has been long La Jolla Pharmaceuticals (Nasdaq: LJPC) calling for a substantial upside in the stock price. At times our thesis has played out such as with the … [Read more...] about La Jolla Pharmaceuticals (Nasdaq: LJPC): An Assessment of The Tetraphase Acquisition
DelMar Pharmaceuticals (NASDAQ: DMPI): A New Beginning
For the past 6-months our team at MS Money Moves has been following the story of DelMar Pharmaceuticals (NASDAQ: DMPI) in an effort to educate and inform the investment community. During this time, we … [Read more...] about DelMar Pharmaceuticals (NASDAQ: DMPI): A New Beginning
LJPC and BCRX Updates: 5/27/20
5/27/20 was the worst day for our team since March 13th when almost every stock on the market was halted due to volatility. Our two largest positions, La Jolla Pharmaceuticals (Nasdaq: LJPC) and … [Read more...] about LJPC and BCRX Updates: 5/27/20
DelMar Pharmaceutical (NASDAQ: DMPI) Remains On Track Despite COVID-19 Crisis
Recap: Since November of 2019 MS Money Moves has been following DelMar Pharmaceuticals (Nasdaq: DMPI) closely through a number of key value inflection points. In my initial article I … [Read more...] about DelMar Pharmaceutical (NASDAQ: DMPI) Remains On Track Despite COVID-19 Crisis
How To Day Trade Stocks
Several of our community members have asked us about how to go about day-trading stocks. In this article I will outline our day-trading strategy using BCRX as an example. What To Look … [Read more...] about How To Day Trade Stocks
Quarterly Update, 1Q20: LJPC
In this article series I go over our core investments, their investment thesis, and new developments during the First Quarter of 2020 (1/1/20 to 3/31/20) starting with LJPC. La Jolla … [Read more...] about Quarterly Update, 1Q20: LJPC
Daily Trade Insights
Updated on 8/10/20Current ResearchClick here to read Sultan's new article on BCRXClick here to read Chris Stand, PharmD's new article on Rapt Therapeutics (RAPT)Click here to read Sultan's LJPC … [Read more...] about Daily Trade Insights
BioCryst Pharmaceuticals (Nasdaq: BCRX) Galidesivir for the Treatment of COVID-19
In a matter of months, a novel strain of coronavirus infamously known as COVID-19 has spiraled from a local outbreak in China into a global pandemic. To date, there have been 1.5M+ confirmed cases and … [Read more...] about BioCryst Pharmaceuticals (Nasdaq: BCRX) Galidesivir for the Treatment of COVID-19
BCRX Updates
With BCRX there are a number of positive features that make it an attractive investment at its current valuation (near 5-year lows; on track to have its second commercial asset approved this year), … [Read more...] about BCRX Updates
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Japanese
Portuguese
Russian
Spanish